XR Securities’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-285
Closed -$236K 89
2024
Q3
$252K Hold
285
0.07% 153
2024
Q2
$258K Sell
285
-1,068
-79% -$854K 0.05% 205
2024
Q1
$1.05M Buy
1,353
+897
+197% +$638K 0.03% 144
2023
Q4
$266K Buy
+456
New +$266K 0.01% 342
2023
Q2
Sell
-7,932
Closed -$3.33M 430
2023
Q1
$2.72M Buy
7,932
+6,790
+595% +$2.29M 0.07% 81
2022
Q4
$418K Sell
1,142
-3,096
-73% -$1.1M 0.04% 313
2022
Q3
$1.37M Buy
+4,238
New +$1.34M 0.75% 29
2022
Q2
Sell
-1,532
Closed -$439K 437
2022
Q1
$439K Buy
+1,532
New +$394K 0.08% 77
2021
Q1
Sell
-2,664
Closed -$521K 527
2020
Q4
$450K Buy
2,664
+1,227
+85% +$183K 0.03% 95
2020
Q3
$213K Buy
+1,437
New +$222K 0.02% 126
2020
Q2
Sell
-2,138
Closed -$297K 275
2020
Q1
$297K Buy
+2,138
New +$294K 0.02% 99
2019
Q2
Sell
-9,499
Closed -$1.23M 320
2019
Q1
$1.23M Buy
9,499
+6,930
+270% +$843K 0.16% 28
2018
Q4
$297K Buy
+2,569
New +$287K 0.13% 104

Other funds holding LLY

XR Securities's LLY Position: Q4 2024 in Review

XR Securities sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 285 shares — an estimated $236K sold.

XR Securities first reported a position in LLY in Q4 2018 and held it in 13 quarters. The position peaked at $2.72M in Q1 2023. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • XR Securities reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
  • XR Securities sold 285 Eli Lilly shares in Q4 2024, an estimated $236K.
  • XR Securities first reported a position in Eli Lilly in Q4 2018 and held it in 13 quarters.
  • XR Securities's Eli Lilly position peaked at $2.72M in Q1 2023.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on XR Securities's 13F filing for Q4 2024, filed 17 Jan 2025.